Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J7503
    Short Description Tacrol envarsus ex rel oral
    Long Description Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
    Pricing indicator 51
    Coverage code D
    ASC payment group code
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2019-01-01
    Date Added 2016-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    68992301001 J7503 Tacrol envarsus ex rel oral Envarsus XR VELOXIS PHARMACEUTICALS 0.25 MG 100 1 400 400
    68992301003 J7503 Tacrol envarsus ex rel oral Envarsus XR VELOXIS PHARMACEUTICALS 0.25 MG 30 1 120 120
    68992304001 J7503 Tacrol envarsus ex rel oral Envarsus XR VELOXIS PHARMACEUTICALS 0.25 MG 100 1 1600 1600
    68992304003 J7503 Tacrol envarsus ex rel oral Envarsus XR VELOXIS PHARMACEUTICALS 0.25 MG 30 1 480 480
    68992307501 J7503 Tacrol envarsus ex rel oral Envarsus XR VELOXIS PHARMACEUTICALS 0.25 MG 100 1 300 300
    68992307503 J7503 Tacrol envarsus ex rel oral Envarsus XR VELOXIS PHARMACEUTICALS 0.25 MG 30 1 90 90
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].